BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND PAX8, ENSG00000125618, 7849
239 results:

  • 1. Relationship between PIWIL1 gene polymorphisms and epithelial ovarian cancer susceptibility among southern Chinese woman: a three-center case-control study.
    Liu S; Yan Y; Cui Z; Feng H; Zhong F; Liu Z; Li Y; Ou X; Li W
    BMC Cancer; 2023 Nov; 23(1):1149. PubMed ID: 38012622
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Neoplasms in Struma Ovarii: A Review.
    Tondi Resta I; Sande CM; LiVolsi VA
    Endocr Pathol; 2023 Dec; 34(4):455-460. PubMed ID: 37864665
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. ovarian Mesonephric-Like Adenocarcinoma With Recurrent Liver Metastases: A Case Report with Analysis of Therapeutic Molecular Targets.
    Sugitani A; Ogawa A; Yoshida H; Kobayashi-Kato M; Kikkawa N; Tanase Y; Uno M; Ishikawa M; Kato T
    Int J Surg Pathol; 2024 May; 32(3):578-585. PubMed ID: 37345348
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Alteration in molecular properties during establishment and passaging of endometrial carcinoma patient-derived xenografts.
    Imai T; Yoshida H; Machida Y; Kuramochi M; Ichikawa H; Kubo T; Takahashi M; Kato T
    Sci Rep; 2023 May; 13(1):8511. PubMed ID: 37231035
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Establishment of a novel model of endometriosis-associated ovarian cancer by transplanting uterine tissue from Arid1a/Pten knockout mice.
    Ono M; Miyamoto T; Asaka R; Uchikawa J; Ando H; Tanaka Y; Shinagawa M; Yokokawa Y; Asaka S; Wang TL; Shih IM; Shiozawa T
    Sci Rep; 2023 May; 13(1):8348. PubMed ID: 37221199
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. SOX17 is a highly sensitive and specific marker for metastatic ovarian and endometrial carcinomas in cytology cell block specimens.
    Satturwar S; Shaker N; Sinclair W; Shen R; Parwani AV; Ding Q; Li Z
    Cancer Cytopathol; 2023 Jul; 131(7):465-470. PubMed ID: 37195085
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Cytopathological characterization of ascites for the diagnosis of serous ovarian carcinoma].
    Chang YH; Zou BQ; Cai Y; Yang SD; Zhang Y; Liang JB; Li C
    Zhonghua Zhong Liu Za Zhi; 2023 May; 45(5):424-432. PubMed ID: 37188628
    [No Abstract]    [Full Text] [Related]  

  • 8. High-grade serous ovarian carcinoma with a sertoliform pattern associated with BRCA mutation: a clinicopathological and molecular analysis.
    Travaglino A; Santoro A; Arciuolo D; Raffone A; Scaglione G; D'Alessandris N; Valente M; Sfregola S; Fulgione C; Onori ME; Minucci A; Zannoni GF
    Virchows Arch; 2023 Dec; 483(6):879-883. PubMed ID: 37166561
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Mixed ovarian Neoplasms With Gastrointestinal-type Mucinous and Mullerian Epithelial Components: A Rare Group of Tumors Demonstrating the Phenotypic Plasticity of the Mullerian Epithelial Cell.
    Chui MH; Ellenson LH
    Am J Surg Pathol; 2023 Jul; 47(7):756-765. PubMed ID: 37125505
    [TBL] [Abstract] [Full Text] [Related]  

  • 10.
    Bulutay P; Vatansever D; Taskiran C; Mericoz CA; Tokat F; Kapucuoglu N; Kulac I
    Indian J Pathol Microbiol; 2023; 66(2):392-395. PubMed ID: 37077094
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [A Case of De Novo Stage Ⅳ Breast cancer with Umbilical Metastasis and Peritoneal Dissemination].
    Mitsuyoshi A; Yanagawa T; Kikumori K; Hori A; Oshima K; Shinke G; Katsuyama S; Ikeshima R; Hiraki M; Ohmura Y; Sugimura K; Masuzawa T; Hata T; Takeda Y; Murata K
    Gan To Kagaku Ryoho; 2023 Mar; 50(3):366-368. PubMed ID: 36927911
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Mesonephric-like adenocarcinoma of the ovary with squamoid morular metaplasia, aberrant β-catenin expression, and concurrent FGFR2 and CTNNB1 mutations: a case report.
    Xu J; Park KJ; Rehrauer WM; Weisman PS
    Virchows Arch; 2024 Jan; 484(1):147-150. PubMed ID: 36856760
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. A comprehensive immunohistochemical analysis of 26 markers in 250 cases of serous ovarian tumors.
    Němejcová K; Šafanda A; Bártů MK; Michálková R; Drozenová J; Fabian P; Hausnerová J; Laco J; Matěj R; Méhes G; Škapa P; Stružinská I; Dundr P
    Diagn Pathol; 2023 Feb; 18(1):32. PubMed ID: 36855066
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. SOX17: A Highly Sensitive and Specific Immunomarker for ovarian and Endometrial Carcinomas.
    Zhang X; Yao J; Niu N; Li X; Liu Y; Huo L; Euscher ED; Wang H; Bell D; Sood AK; Wang G; Lawson BC; Ramalingam P; Malpica A; Sahin AA; Ding Q; Liu J
    Mod Pathol; 2023 Feb; 36(2):100001. PubMed ID: 36853778
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. One biopsy, two tumors: A case report of collision tumor consisting in breast and endometrioid carcinoma detected on bioptic sample of peritoneal carcinomatosis.
    Inzani F; Arciuolo D; Monterossi G; Quagliozzi L; Travaglino A; Santoro A; Valente M; D'Alessandris N; Scaglione G; Sfregola S; Cianfrini F; Zannoni GF
    Pathol Res Pract; 2023 Mar; 243():154378. PubMed ID: 36812738
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Mesonephric Adenomyofibroma: A Biphasic Vaginal Mass of Mesonephric Type With Molecular Analysis: A Case Report of a Rare Entity.
    Shahi M; Palsgrove DN; Ronnett BM; Lin J; Murdock TA
    Int J Gynecol Pathol; 2023 Sep; 42(5):523-528. PubMed ID: 36811844
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Amplified therapeutic targets in high-grade serous ovarian carcinoma - a review of the literature with quantitative appraisal.
    Talbot T; Lu H; Aboagye EO
    Cancer Gene Ther; 2023 Jul; 30(7):955-963. PubMed ID: 36804485
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Identifying SOX17 as a Sensitive and Specific Marker for ovarian and Endometrial Carcinomas.
    Shaker N; Chen W; Sinclair W; Parwani AV; Li Z
    Mod Pathol; 2023 Jan; 36(1):100038. PubMed ID: 36788073
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [Establishment and preliminary application of organoids in ovarian cancer].
    Zhang L; Meng HY; Zhang YS; Miao HX; Yuan L; Zhou SL; Jiang Y; Wan YC; Cheng WW
    Zhonghua Fu Chan Ke Za Zhi; 2023 Feb; 58(2):112-120. PubMed ID: 36776006
    [No Abstract]    [Full Text] [Related]  

  • 20. Evaluation of Lineage/Site-specific Nuclear Immunohistochemical Markers SATB2, Cyclin D1, SALL4, and BCOR in High-grade Endometrial Carcinomas.
    Dyhdalo KS; Ababneh E; Lanigan C; Bowers K; Zhang S; McKenney JK; Joehlin-Price AS
    Int J Gynecol Pathol; 2023 Sep; 42(5):443-450. PubMed ID: 36731037
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 12.